Melanie Dispenza
Physician · Johns Hopkins School of Medicine
Credentials: · · · · · ·
History
- 2019–Present
- 2016–2017
Allergy and Immunology
- 2009–2013
Research
Journal of Investigative Dermatology · 2012 · First of 7 authors · 140 citations
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis
Journal of Clinical Investigation · 2020 · First of 6 authors · 97 citations
Classification of hypersensitivity reactions
Review · Allergy and Asthma Proceedings · 2019 · Sole author · 96 citations
10 papers
5 papers · 5 as a fellow
3 papers
- RS
3 papers
2 papers
2 papers · 2 as a fellow
2 papers
2 papers
Grants
- 2024–2026
Extracellular Vesicles as Biomarkers of Immediate Hypersensitivity Reactions
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $450.3K · Johns Hopkins University
- 2020–2025
Using BTK Inhibitors to Prevent Anaphylactic Drug Reactions
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $1.1M · Johns Hopkins University
Clinical trials
- 2026–2027
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Principal investigator · Recruiting · Phase 1, Phase 2
Johns Hopkins University
- 2021–2022
Preventing Anaphylaxis With Acalabrutinib
Principal investigator · Completed · Phase 2
Johns Hopkins University